The Intracranial Aneurysm Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat aneurysms, which are bulges in the walls of arteries in the brain. These drugs are used to reduce the risk of aneurysm rupture, which can lead to stroke, brain damage, and death. Common treatments include endovascular coiling, which involves inserting a coil into the aneurysm to block blood flow, and surgical clipping, which involves placing a clip on the aneurysm to prevent it from rupturing. The Intracranial Aneurysm Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Johnson & Johnson, Medtronic, Stryker, Boston Scientific, and Terumo. Other companies include Abbott, Merit Medical, and MicroVention. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
